TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05448235

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional treatment
Description: the patient will be asked to make pursed lip breathing (Breathe in for 2 seconds through his nose and Breathe out for 4 seconds through pursed lips)for 5-10 min ,3-4 times , 8-10 rep each cycle then asked to make diaphragmatic breathing exercise (Lie on his/her back and Inhale deeply through his/her nose for a count of three)for 5-10 min , 3-4 times , 8-10 repetition then postural drainage , furthermore the patient takes different position (prone to make percussion on lower lobes, side lying on anterior basal segment then sitting position on the upper lobe). After that a vibration on the chest (place a flat hand firmly atop the lung segment to be drained., and should apply light pressure and create a rapid, shaking movement) 1 min inhale and 5 time of repetition at the exhale and finally asked the patient to make productive cough for 5 times to get out the sputum.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional treatment
Description: the patient will be asked to make pursed lip breathing (Breathe in for 2 seconds through his nose and Breathe out for 4 seconds through pursed lips)for 5-10 min ,3-4 times , 8-10 rep each cycle then asked to make diaphragmatic breathing exercise (Lie on his/her back and Inhale deeply through his/her nose for a count of three)for 5-10 min , 3-4 times , 8-10 repetition then postural drainage , furthermore the patient takes different position (prone to make percussion on lower lobes, side lying on anterior basal segment then sitting position on the upper lobe). After that a vibration on the chest (place a flat hand firmly atop the lung segment to be drained., and should apply light pressure and create a rapid, shaking movement) 1 min inhale and 5 time of repetition at the exhale and finally asked the patient to make productive cough for 5 times to get out the sputum.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: thoracic mobilization
Description: we will use A SNAG to mobilization using type 3 oscillatory and sustain for 90 second, at first put the patient in 3 position (side lying to make mobilization of upper 6 ribs in downward direction then make on lower 6 ribs ,furthermore flexion of the thoracic and next rotation toward the midline then ask the patient to transfer to supine lying position and mobilize the sternum in downward direction the next mobilize the clavicle and ask the patient to take sitting position and put his hand on his head in adduction position and make extension on the thoracic vertebrae with inward mobilize with the investigator knees ,take each 4 vertebrae along the 12 thoracic vertebrae.
Study: NCT06618092

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Relisten
Description: Patients will be attended using Relisten
Study: NCT06620939

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levonorgestrel Intrauterine System (LNG-IUS)
Description: Participants in the intervention group will receive Mirena placement after hysteroscopic polypectomy
Study: NCT05539937

Intervention type: OTHER
Intervention: Quality of life questionnaire
Description: Before TAVI, 30 days, 6 months and twelve months after TAVI, patients will answer TASQ questionnaire,
Study: NCT06314633

Intervention type: OTHER
Group type: OTHER
Intervention: Hair cut
Description: Hair locks and follicles will be cut twice in winter and spring
Study: NCT06481072

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital patient education
Description: This educative intervention includes both medical and psychological explanations, as well as basic strategies to manage pediatric FAPD. The medical information spans the topics of pain, functional abdominal pain and general advice in terms of child health, and the psychological information is based on cognitive-behavioural and pain management theoretical approaches. The intervention consists of six short, animated films with a total run-time of approximately 30 minutes. The films each cover one of the following topics; Why and how do we feel pain? What is functional abdominal pain? How to help: general advice, Thoughts, feelings and behaviour, Goals and strategies. The films are accessed by the patient via 1177.se and maintained on the SoB (Stöd- och behandling) platform that is recognised by the care provider as meeting current safety criteria and standards.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital patient education and iCBT
Description: This includes the educative intervention and a fully digital, four session version of the Aim to Decrease Anxiety and Pain Treatment (ADAPT), a CBT treatment program for FAPD. The treatment focuses on pain-management through the following core elements; The Pain-Gate Theory, breathing and relaxation strategies, calming statements, activity pacing, problem solving and behavior activation. This intervention is also accessed by the patient via 1177.se and maintained on the SoB (Stöd- och behandling) platform.
Study: NCT06306144

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: Arm 1 : Psychoeducation aims to inform patients about post-stroke cognitive impairment, teach them coping strategies to compensate for these difficulties, provide information on symptom recognition and management, and offer emotional and psychological support to help them meet the challenges associated with these potential cognitive impairments.
Study: NCT06314633

Intervention type: OTHER
Group type: OTHER
Intervention: Socio-economic questionnaires
Description: Information about parents education levels and professional occupation, geographic area, children gender, indoor and outdoor children's environmental exposures
Study: NCT05412485

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Robotic assisted gait training
Description: Robotic assisted gait training is advanced technology used in the rehabilitation of neurological injuries and conditions like spinal cord injury, brain injury, stroke, multiple sclerosis, Parkinson's, cerebral palsy. It provides a repetitive task-specific motor training and modulates afferent input to spinal cord to generate rhythmic gait patterns that may be transformed to overground walking. The intensive repetitions of the rhythmic stepping movement during the training stimulates dependent plasticity and it may lead to brain reorganization. It facilitates cortical neural activities associated with motor control of walking.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robotic assisted gait training
Description: Robotic assisted gait training is advanced technology used in the rehabilitation of neurological injuries and conditions like spinal cord injury, brain injury, stroke, multiple sclerosis, Parkinson's, cerebral palsy. It provides a repetitive task-specific motor training and modulates afferent input to spinal cord to generate rhythmic gait patterns that may be transformed to overground walking. The intensive repetitions of the rhythmic stepping movement during the training stimulates dependent plasticity and it may lead to brain reorganization. It facilitates cortical neural activities associated with motor control of walking.
Study: NCT06306144

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computerised Cognitive Stimulation
Description: Arm 2 :Patients will participate in a 6-week cognitive stimulation telerehabilitation intervention, that will consist of two 45-minute sessions per week. Each week they will participate in a 45-minute on-line session with a rehabilitation clinician and later in the week will complete 45 minutes of on-line exercises set by the rehabilitation clinician
Study: NCT05049239

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical training
Description: Medium-high-intensity physical training 3 times a week, 60 min / time for 12 weeks, consisting of fitness, strength and mobility exercises with a target level of 60-90% of maximum heart rate. Two sessions per week take place in a group led by a physiotherapist and once a week the training consists of self-chosen training individually or in group.
Study: NCT06306144

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Arm 3 : No specific care.
Study: NCT05049239

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical training combined with cognitive support.
Description: Medium-high-intensity physical training 3 times a week, 60 min / time for 12 weeks, consisting of fitness, strength and mobility exercises with a target level of 60-90% of maximum heart rate. Two sessions per week take place in a group led by a physiotherapist and once a week the training consists of self-chosen training individually or in group.~The cognitive support consists of person centred individual occupational therapy with focus on daily time management skills and planning and organisation in daily life, i.e. make time for physical exercise. The number of session during the intervention period depend on the participants needs and is estimated to 4-6 sessions.
Study: NCT04686643

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGSAVI
Description: S-amlodipine, Valsartan, Indapamide

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AGLS
Description: S-amlodipine, Valsartan
Study: NCT06163547

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MMA embolization
Description: Middle meningeal artery embolization

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: MMA embolization
Description: Middle meningeal artery embolization
Study: NCT06176352

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Faricimab
Description: Faricimab 6 mg intravitreal (IVT) injection on Day 1 with Q4W PRN treatment thereafter to Week 44. At Week 48, participants will attend a follow-up visit.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ranibizumab
Description: Ranibizumab 0.5 mg intravitreal (IVT) injection on Day 1 with Q4W PRN treatment thereafter to Week 44. At Week 48, participants will attend a follow-up visit.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sham Procedure
Description: The sham is a procedure that mimics an intravitreal (IVT) injection, but involves the blunt end of an empty syringe (without a needle) being pressed against the anesthetized eye. Participants will undergo the sham procedure at study visits where no study drug is to be administered, in order to maintain masking.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sham Procedure
Description: The sham is a procedure that mimics an intravitreal (IVT) injection, but involves the blunt end of an empty syringe (without a needle) being pressed against the anesthetized eye. Participants will undergo the sham procedure at study visits where no study drug is to be administered, in order to maintain masking.
Study: NCT05406518

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Description: Psychosocial intervention based on the model of family therapy.
Study: NCT06658249

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stabilization Exercises with Foot-Ankle Strengthening Program
Description: Core Stabilization Exercises and Foot-Ankle Strengthening Program with the frequency of 3 sets of 10 repetitions 3 times per week for a total duration of 6 weeks. Core Stabilization Exercises include : Double leg Abdominal Press, Single Leg Abdominal Press, Abdominal crunches, Side-lying Hip Abduction, Bridging Exercise, Wall Squats Exercise. Foot-Ankle Strengthening Program include : Step ups Exercise, Heel Raises in standing/sitting, Toe Raises in standing/sitting, Foot-Ankle isometrics with theraband, One leg balance with chair support. Pre and Post intervention values will be taken on 1st day and after 6 weeks. Simple Conventional treatment will also given that include Hot Pack and TENS for 10 minutes and Ultrasound for 5 minutes and Knee Isometric exercises with the frequency of 1 set of 10 repetitions with 5 sec hold with the ratio of 3 times per week for a total duration of 6 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Foot-Ankle Strengthening Program
Description: Foot-Ankle Strengthening Program along with common conventional treatment with the frequency of 3 sets of 10 repetition thrice per week for a total duration of 6 weeks. Core Stabilization Exercises include : Double leg Abdominal Press, Single Leg Abdominal Press, Abdominal crunches, Side-lying Hip Abduction, Bridging Exercise, Wall Squats Exercise. Foot-Ankle Strengthening Program include : Step ups Exercise, Heel Raises in standing/sitting, Toe Raises in standing/sitting, Foot-Ankle isometrics with theraband, One leg balance with chair support. Pre and Post intervention values will be taken on 1st day and after 6 weeks. Simple Conventional treatment will also given that include Hot Pack and TENS for 10 minutes and Ultrasound for 5 minutes and Knee Isometric exercises with the frequency of 1 set of 10 repetitions with 5 sec hold with the ratio of 3 times per week for a total duration of 6 weeks.
Study: NCT06036810

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shared Medical Decision Tool
Description: standard of care
Study: NCT06627881

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Continuous aerobic kayak training program
Description: Sitting in a special chair on the Kayak Pro® Speed Stroke PRO ergometer. 5-minute warm-up and continuous training, for 30 minutes on the ergometer at a moderate to vigorous intensity, 5 days a week.
Study: NCT06036810

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shared Medical Decision Tool
Description: standard of care

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Engaging Patients in Decision Making
Description: standard of care

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Engaging Patients in Decision Making
Description: standard of care

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Literacy Spanish Language
Description: standard of care

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Literacy Spanish Language
Description: standard of care
Study: NCT06590337

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Spark Placebo Control Form 1
Description: Participants will use their Radicle Spark Placebo Control Form 1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Spark Active Study Product 1.1 Usage
Description: Participants will use their Radicle Spark Active Study Product 1.1 as directed for a period of 6 weeks.
Study: NCT05312879

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-147
Description: Tablets for oral administration.
Study: NCT06590337

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Spark Placebo Control Form 2
Description: Participants will use their Radicle Spark Placebo Control Form 2 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Spark Active Study Product 2.1 Usage
Description: Participants will use their Radicle Spark Active Study Product 2.1 as directed for a period of 6 weeks.
Study: NCT04816292

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Hot Snare Polypectomy
Description: Hot Snare Polypectomy with the use of electrocautery for the resection of polyps.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Experimental: Cold Snare Polypectomy
Description: Cold Snare Polypectomy without the use of electrocautery for the resection of polyps.
Study: NCT06347744

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Radicle Rest Placebo Control Form 1
Description: Participants will use their Radicle Rest Placebo Control Form 1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Radicle Rest Active Study Product 1.1 Usage
Description: Participants will use their Radicle Rest Active Study Product 1.1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Radicle Rest Placebo Control Form 2
Description: Participants will use their Radicle Rest Placebo Control Form 2 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Radicle Rest Active Study Product 2.1 Usage
Description: Participants will use their Radicle Rest Active Study Product 2.1 as directed for a period of 6 weeks.
Study: NCT06011889

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etanercept
Description: treatment with etanercept in addition to NSAID treatment and/or classic Disease Modifying Antirheumatic Drugs

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: treatment with placebo in addition to NSAID treatment and/or classic Disease Modifying Antirheumatic Drugs
Study: NCT04867434

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RZL-012
Description: small synthetic molecule for submental fat reduction

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RZL-012
Description: small synthetic molecule for submental fat reduction

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06288789

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Social Frailty Index
Description: Social Frailty Index will be applied twice, one week apart.
Study: NCT05029973

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAIC
Description: hepatic arterial infusion (HAI) of oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg IV d1,Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab Biosimilar
Description: 7.5mg/kg IV d1,Q3W
Study: NCT05312879

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-147
Description: Tablets for oral administration.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablets for oral administration.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablets for oral administration.
Study: NCT06563895

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acoramidis
Description: TTR stabilizer administered orally twice daily (BID)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Non-active control administered orally twice daily (BID)
Study: NCT06642545

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin
Description: Disitamab Vedotin 2.0mg/kg,intravenous infusion, every 2 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC148
Description: 20mg/kg, intravenous infusion, once every 2 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin-bound Paclitaxone
Description: 125 mg/m2,intravenous infusion, D1-8, every 3 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Toripalimab
Description: 240mg,intravenous infusion, once every 3 weeks
Study: NCT06641232

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Comparison of anesthetic efficacy and safety between nerve block and infiltrative technique for mandibular posterior implant placement.
Description: The surgeon and his assistant will leave the operating room and the study investigator in charge of anesthetizing the patients (XA) will enter.~The anesthesia will be performed by an investigator other than the surgeon performing the procedure. The patient will be assigned to a treatment group; patients in the control group will undergo vestibular and lingual infiltration, while the experimental group will undergo inferior dental nerve block together with buccal nerve block.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Comparison of anesthetic efficacy and safety between nerve block and infiltrative technique for mandibular posterior implant placement.
Description: The surgeon and his assistant will leave the operating room and the study investigator in charge of anesthetizing the patients (XA) will enter.~The anesthesia will be performed by an investigator other than the surgeon performing the procedure. The patient will be assigned to a treatment group; patients in the control group will undergo vestibular and lingual infiltration, while the experimental group will undergo inferior dental nerve block together with buccal nerve block.
Study: NCT06257277

Intervention type: DRUG
Intervention: GBCAs
Description: GBCAs are given per routine clinical practice.
Study: NCT05309629

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QL1706
Description: Intravenous infusions of QL1706 5mg/kg on Day 1 of every 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin intravenous infusion to achieve an initial target AUC of 5 mg/mL/min was administered on Day 1 of each 21-day cycle for 4-6 cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Etoposide intravenous infusion was administered at a dose of 100 mg/m\^2 on Days 1, 2, and 3 of each 21-day cycle for 4-6 cycles.
Study: NCT06581224

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Primary Hospital Provider Team
Description: The PHP team aims to enhance continuity during hospital readmissions with a consistent cohort of seven hospital medicine physicians and two advanced practice providers (APPs). To improve care transitions, the team will have an integrated case manager who will continue following PHP patients during subsequent hospitalizations. Physicians will follow a standard seven-day service schedule, with the two APPs alternating five-to-seven-day periods. Daily huddles between physicians and APPs will further promote continuity. During the index admission, the PHP team will create a care plan in consultation with the patient to improve standardization of inpatient care and transition to outpatient settings. Communication will be a core tenet of the team, with scheduled monthly team meetings of physicians, APPs, case manager, dyad partner, and representatives from nursing and therapy services to revise individualized care plans for PHP patients and brainstorm solutions for complex challenges.
Study: NCT06431347

Intervention type: BEHAVIORAL
Intervention: Social Determinants of Health Questionnaire
Description: Participants will also complete a questionnaire about financial barriers to care within the past year, including income bracket and difficulty affording cost-of-living or medical expenses.